Prevention and management of adverse events related to regorafenib

Regorafenib is an oral multikinase inhibitor that has shown antitumor activity in a range of solid tumors. Based on data from phase III clinical trials, regorafenib is indicated for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not co...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: De Wit, Mieke, Boers-Doets, Christine B., Saettini, Alessandra, Vermeersch, Kristina, de Juan, Carmen Roncero, Ouwerkerk, Jan, Raynard, See-See, Bazin, Ashley, Cremolini, Chiara
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2013
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913844/
https://ncbi.nlm.nih.gov/pubmed/24337717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-013-2085-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker